Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

25.68
-0.3100-1.19%
Volume:797.69K
Turnover:20.44M
Market Cap:4.10B
PE:-62.44
High:25.99
Open:25.63
Low:25.10
Close:25.99
52wk High:26.16
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.61
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:28.71
PE(LYR):-65.48

Loading ...

Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 18, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities